XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses:    
Research and development $ 22,963 $ 17,445
General and administrative 4,288 3,990
Total operating expenses 27,251 21,435
Loss from operations (27,251) (21,435)
Other income:    
Interest income 800 7
Other income, net 1,179 620
Total other income 1,979 627
Net loss $ (25,272) $ (20,808)
Net loss per share, basic (in USD per share) $ (0.58) $ (0.74)
Net loss per share, diluted (in USD per share) $ (0.58) $ (0.74)
Weighted-average common shares outstanding, basic (in shares) 43,664,783 28,127,288
Weighted-average common shares outstanding, diluted (in shares) 43,664,783 28,127,288